John Burns Net Worth

The estimated Net Worth of John Thomas Burns is at least $480 millier dollars as of 5 December 2022. Mr. Burns owns over 1,159 units of SELLAS Life Sciences Inc stock worth over $38,738 and over the last 8 years he sold SLS stock worth over $4,450. In addition, he makes $436,727 as Interim Principal Accounting Officer, Vice President - Finance et Corporate Controller at SELLAS Life Sciences Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Burns SLS stock SEC Form 4 insiders trading

John has made over 2 trades of the SELLAS Life Sciences Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 1,159 units of SLS stock worth $3,002 on 5 December 2022.

The largest trade he's ever made was selling 1,159 units of SELLAS Life Sciences Inc stock on 5 December 2022 worth over $3,002. On average, John trades about 139 units every 37 days since 2017. As of 5 December 2022 he still owns at least 29,347 units of SELLAS Life Sciences Inc stock.

You can see the complete history of Mr. Burns stock trades at the bottom of the page.

John Burns biography

John Thomas Burns CPA serves as Interim Principal Accounting Officer, Vice President - Finance, Corporate Controller of the Company. Mr. Burns has served as the Company’s Vice President, Finance and Corporate Controller since December 2017. Burns has over 10 years’ experience in finance and accounting. Mr. Burns joined the Company in May 2013 and has held various positions of increasing responsibility during his tenure. Prior to joining the Company, Mr. Burns was a Securities and Exchange Reporting Manager at Pixelworks, Inc. (NASDAQ: PSLW), and began his career in public accounting at Moss Adams LLP. Burns received a B.S.M. in Finance and Master of Accounting degree from Tulane University. He is an active Certified Public Accountant. On December 17, 2018, the Board of Directors of the Company appointed Mr. Burns as the Company’s interim principal accounting officer.

What is the salary of John Burns?

As the Interim Principal Accounting Officer, Vice President - Finance et Corporate Controller of SELLAS Life Sciences Inc, the total compensation of John Burns at SELLAS Life Sciences Inc is $436,727. There are 5 executives at SELLAS Life Sciences Inc getting paid more, with Angelos Stergiou having the highest compensation of $1,426,610.

How old is John Burns?

John Burns is 35, he's been the Interim Principal Accounting Officer, Vice President - Finance et Corporate Controller of SELLAS Life Sciences Inc since 2018. There are 14 older and no younger executives at SELLAS Life Sciences Inc. The oldest executive at SELLAS Life Sciences Group Inc is David Scheinberg, 64, who is the Director.

What's John Burns's mailing address?

John's mailing address filed with the SEC is 2000 Crow Canyon Pl #380, San Ramon, CA 94583, USA.

Insiders trading at SELLAS Life Sciences Inc

Over the last 7 years, insiders at SELLAS Life Sciences Inc have traded over $74,616 worth of SELLAS Life Sciences Inc stock. The most active insiders traders include John Varian, Jane Wasman et David A Scheinberg. On average, SELLAS Life Sciences Inc executives and independent directors trade stock every 205 days with the average trade being worth of $6,842. The most recent stock trade was executed by Angelos M. Stergiou on 5 December 2022, trading 6,494 units of SLS stock currently worth $16,949.

What does SELLAS Life Sciences Inc do?

σellas life sciences is a healthcare-oriented global group of companies with a unique and innovative vision, which is ambitious, yet clear: to practice the medicine of tomorrow, today. in other words, we incorporate innovation throughout all our activities aiming at breakthroughs that will have a significant impact on the thinking and practicing of healthcare worldwide. our international team of acknowledged scientists, doctors and health professionals along with a seasoned and highly experienced pharmaceutical executive management form the core of σellas. we strive to improve patients' quality of life through developing and commercializing cutting-edge drugs, medical devices and innovative therapies.

Complete history of Mr. Burns stock trades at SELLAS Life Sciences Inc

SELLAS Life Sciences Inc executives and stock owners

SELLAS Life Sciences Inc executives and other stock owners filed with the SEC include:

• Angelos Stergiou,
  President, Chief Executive Officer, Director
• Dr. Angelos M. Stergiou M.D., ScD h.c.,
  Founder, Pres, CEO & Director
• Barbara Wood,
  Executive Vice President, General Counsel, Corporate Secretary
• Barbara A. Wood,
  Exec. VP, Gen. Counsel & Sec.
• Dr. Dragan Cicic M.D., MBA,
  Sr. VP of Clinical Devel.
• John Burns,
  Interim Principal Accounting Officer, Vice President - Finance, Corporate Controller
• Dr. Dragan Cicic,
  Sr. VP of Clinical Devel.
• Jane Wasman,
  Independent Chairman of the Board
• John Varian,
  Independent Director
• Robert Van Nostrand,
  Independent Director
• David Scheinberg,
  Director
• Dragan Cicic,
  Senior Vice President - Clinical Development
• Jörg W. Breitkopf,
  Head of Clinical Operations
• Robert M. Francomano,
  Sr. VP & Chief Commercial Officer
• John Thomas Burns CPA,
  Sr. VP of Fin. & Chief Accounting Officer
• David D. Moser,
  VP of Legal Affairs
• Jörg W. Breitkopf,
  Head of Clinical Operations
• Dr. Christopher R. Shackleton,
  Director of Clinical and Bus. Operations
• Martin G. Baum,
  Chief Operating Officer
• John Thomas Burns CPA, CPA,
  VP of Fin., Corp. Controller & Chief Accounting Officer
• Fabio Lopez,
  Director
• Nicholas J. Sarlis,
  Chief Medical Officer and SVP
• Robert Francomano,
  Chief Commercial Officer
• Fabio Eqc Private Markets S...,
  
• Stephen F Ghiglieri,
  Director
• Gregory M Torre,
  CRO and SVP
• Fabio Eqc Private Markets S...,
  
• Gene Mack,
  CFO and Treasurer
• Katherine Bach Kalin,
  Director